Coriolis Pharma
Daniel Weinbuch is a skilled professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Business Development Manager and Scientific Marketing Specialist at Coriolis Pharma, Daniel has also held positions as a Senior Scientist and PhD student, contributing to studies on receptor-ligand interactions related to cancer. Prior roles include an internship at Coriolis Pharma, a visiting scientist position at Kobe Pharma Research Institute, and internships at Boehringer Ingelheim Pharmaceuticals and Merckle GmbH. Daniel holds a PhD in Bio-Pharmaceutical Sciences from Leiden University and has a strong foundation in pharmaceutical production and quality control, gained through education and early career apprenticeships.
This person is not in any teams
Coriolis Pharma
2 followers
Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2. Formulation research and development (from pre-formulation to market formulations) Analytical method development (aggregate and particle characterization, protein analytics, GMP analytics) Forced degradation and stability testing (stress conditions tailored for the product, stability testing according ICH) Lyophilization (cycle development, scale up, modern PAT-tools) Supply of pre-clinical material (GMP-like conditions in clean room)